Clinical Trials Directory

Trials / Completed

CompletedNCT02908828

Calanus Oil Supplementation and Maximal Oxygen Uptake

Effect of Copepod Oil Supplementation (Calanus Finmarchicus) on Endurance and VO2max in Healthy Obese Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

Copepod oil is extracted from the marine copepod Calanus finmarchicus, the dominant plankton species in the marine food web in the Norwegian Sea. Copepods constitute the largest renewable and harvestable resource in the Norwegian Sea and adjacent waters, and it is now developed knowledge and technology for sustainable harvesting of this "new" resource. The purpose of this study is to investigate whether Calanus copepod oil supplementation has an equivalent effect on maximal oxygen uptake in humans to that seen in experimental studies in mice.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCalanus oil
DIETARY_SUPPLEMENTplacebo dietary oil

Timeline

Start date
2016-10-01
Primary completion
2017-09-19
Completion
2017-09-19
First posted
2016-09-21
Last updated
2020-09-30

Locations

2 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT02908828. Inclusion in this directory is not an endorsement.